Thus, CDK8/19i prevent the quiescence-mediated escape from BCR-ABLi-induced apoptosis, suggesting a strategy for avoiding the CML relapse. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.